Although further studies will be needed to disentangle the biological meaning of this finding, we could speculate that the observed pathway-level negative genetic covariance between ASD and MetS might reflect higher complexity of reciprocal regulation between monoamine and insulin signalling at the CNS and peripheral level [12]. The gene discussed is INS; the disease is metabolic syndrome.